Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
METformin for the MINimization of Geographic Atrophy Progression (METforMIN): A Randomized Trial.
Shen LL, Keenan JD, Chahal N, Taha AT, Saroya J, Ma CJ, Sun M, Yang D, Psaras C, Callander J, Flaxel C, Fawzi AA, Schlesinger TK, Wong RW, Bryan Leung LS, Eaton AM, Steinle NC, Telander DG, Afshar AR, Neuwelt MD, Lim JI, Yiu GC, Stewart JM. Shen LL, et al. Among authors: yiu gc. Ophthalmol Sci. 2023 Dec 4;4(3):100440. doi: 10.1016/j.xops.2023.100440. eCollection 2024 May-Jun. Ophthalmol Sci. 2023. PMID: 38284098 Free PMC article.
Association of Hyperautofluorescence Signals with Geographic Atrophy Progression in the METformin for the MINimization of Geographic Atrophy Progression Trial.
Taha AT, Shen LL, Diaz A, Chahal N, Saroya J, Sun M, Allingham MJ, Farsiu S, Yiu G, Keenan JD, Stewart JM. Taha AT, et al. Among authors: yiu g. Ophthalmol Sci. 2024 Sep 12;5(1):100620. doi: 10.1016/j.xops.2024.100620. eCollection 2025 Jan-Feb. Ophthalmol Sci. 2024. PMID: 39584185 Free PMC article.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel Guidance.
Wykoff CC, Avery RL, Barakat MR, Boyer DS, Brown DM, Brucker AJ, Cunningham ET Jr, Heier JS, Holekamp NM, Kaiser PK, Khanani AM, Kim JE, Demirci H, Regillo CD, Yiu GC, Ciulla TA. Wykoff CC, et al. Retina. 2024 Jun 1;44(6):939-949. doi: 10.1097/IAE.0000000000004087. Retina. 2024. PMID: 38451179
Performance of Automated Machine Learning in Predicting Outcomes of Pneumatic Retinopexy.
Nisanova A, Yavary A, Deaner J, Ali FS, Gogte P, Kaplan R, Chen KC, Nudleman E, Grewal D, Gupta M, Wolfe J, Klufas M, Yiu G, Soltani I, Emami-Naeini P. Nisanova A, et al. Among authors: yiu g. Ophthalmol Sci. 2024 Jan 19;4(5):100470. doi: 10.1016/j.xops.2024.100470. eCollection 2024 Sep-Oct. Ophthalmol Sci. 2024. PMID: 38827487 Free PMC article.
174 results